Blackstone’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Blackstone's NKTR Position: Q2 2026 in Review
Blackstone opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 28,678 shares worth $2M. The stake represents 0.01% of the portfolio and ranks #182 among its holdings.
242 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.
- Blackstone held 28,678 shares of Nektar Therapeutics worth $2M as of Q2 2026.
- Nektar Therapeutics was a new Blackstone position in Q2 2026.
- Nektar Therapeutics made up 0.01% of Blackstone's portfolio in Q2 2026, its #182 holding.
- 242 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.